Retinoblastoma

The Lancet

Volumn 379, Issue 9824, 2012, Pages 1436-1446

  Dimaras, Helen ^a,e,h   Kimani, Kahaki ^b   Dimba, Elizabeth A O ^c   Gronsdahl, Peggy ^d   White, Abby ^e   Chan, Helen S L ^a,e,g   Gallie, Brenda L ^a,e,f,h  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b KENYATTA NATIONAL HOSPITAL   (Kenya)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d Canadian Retinoblastoma Society   (Canada)

^e Daisy's Eye Cancer Fund   (United Kingdom)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; RETINOBLASTOMA BINDING PROTEIN 1; THIOTEPA; TOPOTECAN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AWARENESS; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CELL CYCLE REGULATION; CELL SURVIVAL; CHILD CARE; CHROMOSOME 13Q; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; EARLY DIAGNOSIS; ENUCLEATION; EVIDENCE BASED PRACTICE; FAMILY; FAMILY COPING; FOLLOW UP; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; GENOMIC INSTABILITY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INCOME; LEUKOKORIA; LONG TERM CARE; LOSS OF FUNCTION MUTATION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENT; PATIENT CARE; PATIENT PARTICIPATION; PHASE 1 CLINICAL TRIAL (TOPIC); POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY OF LIFE; RETINOBLASTOMA; SOCIOECONOMICS; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR VOLUME; VISION; WELLBEING;

EID: 84859586247     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61137-9     Document Type: Conference Paper

References (92)

1. DE Comings A general theory of carcinogenesis Proc Natl Acad Sci USA 70 1973 3324 3328
2. SH Friend, R Bernards, S Rogelj et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Nature 323 1986 643 646
3. AG Knudson Jr Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci USA 68 1971 820 823
4. T Kivela The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death Br J Ophthalmol 93 2009 1129 1131
5. CM Chuka-Okosa, NJ Uche, NN Kizor-Akaraiwe Orbito-ocular neoplasms in Enugu, South-Eastern, Nigeria West Afr J Med 27 2008 144 147
6. MO Samaila Malignant tumours of childhood in Zaria Afr J Paediatr Surg 6 2009 19 23
7. A MacCarthy, GJ Draper, E Steliarova-Foucher, JE Kingston Retinoblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project Eur J Cancer 42 2006 2092 2102
8. BS Menon, J Alagaratnam, E Juraida, M Mohamed, H Ibrahim, NN Naing Late presentation of retinoblastoma in Malaysia Pediatr Blood Cancer 52 2009 215 217
9. LY Kao, WW Su, YW Lin Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000 Jpn J Ophthalmol 46 2002 577 580
10. T Boubacar, S Fatou, T Fousseyni et al. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali Br J Ophthalmol 94 2010 467 469
11. JF Owoeye, EA Afolayan, DS Ademola-Popoola Retinoblastoma - a clinico-pathological study in Ilorin, Nigeria Afr J Health Sci 13 2006 117 123
12. RJ Bowman, M Mafwiri, P Luthert, J Luande, M Wood Outcome of retinoblastoma in east Africa Pediatr Blood Cancer 50 2008 160 162
13. Nyamori JM, Kimani K, Njuguna MW, Dimaras H. The incidence and distribution of retinoblastoma in Kenya. Br J Ophthalmol (in press).
14. C Leal-Leal, M Flores-Rojo, A Medina-Sanson et al. A multicentre report from the Mexican Retinoblastoma Group Br J Ophthalmol 88 2004 1074 1077
15. DH Abramson, CM Frank, M Susman, MP Whalen, IJ Dunkel, NW Boyd 3rd Presenting signs of retinoblastoma J Pediatr 132 1998 505 508
16. C Leander, LC Fu, A Pena et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras Pediatr Blood Cancer 49 2007 817 819
17. KE Rodrigues, R Latorre Mdo, B de Camargo Delayed diagnosis in retinoblastoma J Pediatr (Rio J) 80 2004 511 516 (in Portuguese).
18. AC Mallipatna, JE Sutherland, BL Gallie, H Chan, E Heon Management and outcome of unilateral retinoblastoma J AAPOS 13 2009 546 550
19. Canadian Retinoblastoma Society National Retinoblastoma Strategy Canadian guidelines for care: stratégie thérapeutique du rétinoblastome guide clinique canadien Can J Ophthalmol 44 suppl 2 2009 S1 88
20. AG Goddard, JE Kingston, JL Hungerford Delay in diagnosis of retinoblastoma: risk factors and treatment outcome Br J Ophthalmol 83 1999 1320 1323
21. DH Abramson, K Beaverson, P Sangani et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival Pediatrics 112 2003 1248 1255
22. P Finger, J Harbour, A Murphree et al. Chapter 52: retinoblastoma SB Edge DR Byrd CC Compton AG Fritz FL Greene A Trotti AJCC Cancer Staging Manual, 7th edn. 2010 Springer Science and Business Media Berlin 561 568
23. Linn Murphree A Intraocular retinoblastoma: the case for a new group classification Ophthalmol Clin North Am 18 2005 41 53
24. S Canturk, I Qaddoumi, V Khetan et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators Br J Ophthalmol 94 2010 1432 1436
25. M Pezzente Personal story http://www.rbsociety.ca/story-mariapezzente. html 2009 (accessed Dec 13, 2011).
26. H Dimaras, A White, BL Gallie The Kenyan National Retinoblastoma Strategy: building local capacity in the diagnosis and management of pediatric eye cancer in Kenya http://www.ophthalmologyrounds.ca/crus/ophthcdneng0708-08. pdf 2008 (accessed Dec 13, 2011).
27. K Kimani, B Ouma, B Gallie et al. Rati's challenge: a vision for Africa - report from the first Kenyan National Retinoblastoma Strategy meeting http://www.daisyseyecancerfund.org/Files/Reports/ratischallenge3.pdf Feb 16, 2009 (accessed Dec 13, 2011)
28. TP Dryja, S Friend, RA Weinberg Genetic sequences that predispose to retinoblastoma and osteosarcoma Symp Fundam Cancer Res 39 1986 115 119
29. WH Lee, JY Shew, FD Hong et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity Nature 329 1987 642 645
30. H Dimaras, V Khetan, W Halliday et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma Hum Mol Genet 17 2008 1363 1372
31. TW Corson, BL Gallie One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma Genes Chromosomes Cancer 46 2007 617 634
32. DL Burkhart, J Sage Cellular mechanisms of tumour suppression by the retinoblastoma gene Nat Rev Cancer 8 2008 671 682
33. S Talluri, CE Isaac, M Ahmad et al. A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence Mol Cell Biol 30 2010 948 960
34. CE Isaac, SM Francis, AL Martens et al. The retinoblastoma protein regulates pericentric heterochromatin Mol Cell Biol 26 2006 3659 3671
35. MS Longworth, NJ Dyson pRb, a local chromatin organizer with global possibilities Chromosoma 119 2010 1 11
36. S Richter, K Vandezande, N Chen et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma Am J Hum Genet 72 2003 253 269
37. C Eng, FP Li, DH Abramson et al. Mortality from second tumors among long-term survivors of retinoblastoma J Natl Cancer Inst 85 1993 1121 1128
38. XP Zhu, JM Dunn, RA Phillips et al. Preferential germline mutation of the paternal allele in retinoblastoma Nature 340 1989 312 313
39. TP Dryja, S Mukai, R Petersen, JM Rapaport, D Walton, DW Yandell Parental origin of mutations of the retinoblastoma gene Nature 339 1989 556 558
40. D Rushlow, B Piovesan, K Zhang et al. Detection of mosaic RB1 mutations in families with retinoblastoma Hum Mutat 30 2009 842 851
41. M Zeschnigk, D Lohmann, B Horsthemke A PCR test for the detection of hypermethylated alleles at the retinoblastoma locus J Med Genet 36 1999 793 794
42. DR Lohmann, B Brandt, W Hopping, E Passarge, B Horsthemke Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma Hum Genet 94 1994 349 354
43. GA Otterson, W Chen, AB Coxon, SN Khleif, FJ Kaye Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function Proc Natl Acad Sci USA 94 1997 12036 12040
44. O Baud, V Cormier-Daire, S Lyonnet, L Desjardins, C Turleau, F Doz Dysmorphic phenotype and neurological impairment in 22 retinoblastoma patients with constitutional cytogenetic 13q deletion Clin Genet 55 1999 478 482
45. JJ Yunis, N Ramsay Retinoblastoma and subband deletion of chromosome 13 Am J Dis Child 132 1978 161 163
46. D DiCiommo, BL Gallie, R Bremner Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer Semin Cancer Biol 10 2000 255 269
47. P Albrecht, B Ansperger-Rescher, A Schuler, M Zeschnigk, B Gallie, DR Lohmann Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression Hum Mutat 26 2005 437 445
48. American Society of Clinical Oncology American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility J Clin Oncol 21 2003 2397 2406
49. AC Mallipatna, H Dimaras, HSL Chan, E Héon, BL Gallie Periocular topotecan for intraocular retinoblastoma Arch Ophthalmol 129 2011 738 745
50. C Houdayer, M Gauthier-Villars, A Lauge et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF Hum Mutat 23 2004 193 202
51. H Dimaras, D Rushlow, W Halliday et al. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma Transl Res 156 2010 91 97
52. BL Gallie, RM Ellsworth, DH Abramson, RA Phillips Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 45 1982 513 521
53. E Bowles, TW Corson, J Bayani et al. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1 Genes Chromosomes Cancer 46 2007 118 129
54. MN Marchong, C Yurkowski, C Ma, C Spencer, S Pajovic, BL Gallie Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death PLoS Genet 6 2010 e1000923
55. TJ Hudson, W Anderson, A Artez et al. International network of cancer genome projects Nature 464 2010 993 998
56. AB Reese, RM Ellsworth The evaluation and current concept of retinoblastoma therapy Trans Am Acad Ophthalmol Otolaryngol 67 1963 164 172
57. HS Chan, PS Thorner, G Haddad, BL Gallie Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression Ophthalmol 98 1991 1425 1431
58. HS Chan, MD Canton, BL Gallie Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines Anticancer Res 9 1989 469 474
59. CA Mallipatna, H Dimaras, E Héon, BL Gallie Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies: an analysis of impact Evidence-Based Ophthalmol 10 2009 183 185
60. DE Novetsky, DH Abramson, JW Kim, IJ Dunkel Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies - an analysis of impact Ophthalmic Genet 30 2009 40 44
61. T Kivela, A Singh Information for authors project http://eyecancerbig. com/EyeCaBIG/Journals-and-Societies.html 2011 (accessed Dec 13, 2011).
62. J Zhao, H Dimaras, C Massey et al. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis J Clin Oncol 29 2011 845 851
63. D Shome, SG Honavar, K Raizada, D Raizada Implant and prosthesis movement after enucleation: a randomized controlled trial Ophthalmology 117 2010 1638 1644
64. H Dimaras, E Heon, A Budning et al. Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation Ophthalmic Genet 30 2009 121 126
65. C McDaid, S Hartley, AM Bagnall, G Ritchie, K Light, R Riemsma Systematic review of effectiveness of different treatments for childhood retinoblastoma Health Technol Assess 9 2005 1 145
66. GL Chantada, AC Fandino, AM Carcaboso et al. A phase I study of periocular topotecan in children with intraocular retinoblastoma Invest Ophthalmol Vis Sci 50 2009 1492 1496
67. HS Chan, BL Gallie, FL Munier, M Beck Popovic Chemotherapy for retinoblastoma Ophthalmol Clin North Am 18 2005 55 63
68. RA Kleinerman, MA Tucker, DH Abramson, JM Seddon, RE Tarone, JF Fraumeni Jr Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma J Natl Cancer Inst 99 2007 24 31
69. HS Chan, G DeBoer, JJ Thiessen et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation Clin Cancer Res 2 1996 1499 1508
70. HB Stallard Irradiation of retinoblastoma (glioma retinæ) Lancet 1 1952 1046 1049
71. RA Kleinerman, MA Tucker, RE Tarone et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up J Clin Oncol 23 2005 2272 2279
72. O Fletcher, D Easton, K Anderson, C Gilham, M Jay, J Peto Lifetime risks of common cancers among retinoblastoma survivors J Natl Cancer Inst 96 2004 357 363
73. A Sahgal, BA Millar, H Michaels et al. Focal stereotactic external beam radiotherapy as a vision-sparing method for the treatment of peripapillary and perimacular retinoblastoma: preliminary results Clin Oncol (R Coll Radiol) 18 2006 628 634
74. DH Abramson, CM Frank, IJ Dunkel A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma Ophthalmology 106 1999 1947 1950
75. A Mulvihill, A Budning, V Jay et al. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma Arch Ophthalmol 121 2003 1120 1124
76. I Schmack, G Baker Hubbard, SJ Kang, TM Aaberg, HE Grossniklaus Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma Am J Ophthalmol 142 2006 310 315
77. T Yamane, A Kaneko, M Mohri The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma Int J Clin Oncol 9 2004 69 73
78. S Suzuki, T Yamane, M Mohri, A Kaneko Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis Ophthalmology 118 2011 2081 2087
79. DH Abramson, IJ Dunkel, SE Brodie, B Marr, YP Gobin Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery) Ophthalmology 117 2010 1623 1629
80. DH Abramson, IJ Dunkel, SE Brodie, JW Kim, YP Gobin A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results Ophthalmology 115 2008 1398 1404
81. DH Abramson, IJ Dunkel, SE Brodie, B Marr, YP Gobin Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy Arch Ophthalmol 128 2010 370 372
82. HA Aziz, H Boutrid, TG Murray et al. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma Retina 30 suppl 4 2010 S63 S65
83. CL Shields, A Ramasubramanian, R Rosenwasser, JA Shields Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma Retina 29 2009 1207 1209
84. PK Duffner Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors Neurologist 10 2004 293 310
85. IJ Dunkel, A Aledo, NA Kernan et al. Successful treatment of metastatic retinoblastoma Cancer 89 2000 2117 2121
86. C Rodriguez-Galindo, MW Wilson, BG Haik et al. Treatment of metastatic retinoblastoma Ophthalmology 110 2003 1237 1240
87. IJ Dunkel, RF Jubran, S Gururangan et al. Trilateral retinoblastoma: potentially curable with intensive chemotherapy Pediatr Blood Cancer 54 2010 384 387
88. AC Paulino Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer 86 1999 135 141
89. H Dimaras, E Heon, J Doyle et al. Multifaceted chemotherapy for trilateral retinoblastoma Arch Ophthalmol 129 2011 362 365
90. S Dai, E Heon, A Budning et al. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction Ophthalmic Genet 29 2008 120 125
91. S Bhasker, V Bajpai, A Turaka Palliative radiothedrapy in paediatric malignancies Singapore Med J 49 2008 998 1001
92. RL Panton, R Downie, T Truong et al. A visual approach to providing prognostic information to parents of children with retinoblastoma Psychooncology 18 2009 300 304